Gut bacteria as an approach to the treatment of chronic intestinal inflammation

17 Dec, 2019

DFG funds new research group "miTarget" at Kiel University with seven million euros

miTarget consists of nine individual research projects, each dealing with partial aspects of the topic. A subproject deals, for example, with changes in the microbiome during pregnancy and the influence of these changes on the further course of inflammatory bowel diseases.

Prof. Andre Franke, speaker of the RTG 1743, Director at the Institute for Clinical Molecular Biology (IKMB), CAU and UKSH, and board member of the PMI Cluster of Excellence, is the spokesman for the DFG research group "miTarget: The microbiome as a therapeutic target in inflammatory bowel diseases"

You can find more information here. (Sorry in German only)